Skip to main content
. 2021 Apr 8;9(4):402. doi: 10.3390/biomedicines9040402

Table 2.

Study cohort: patients’ clinicopathological data.

SEX AGE GRADE STAGE * METASTASES
Male Female 50 year ≥ x 50 year ≤ x Low (0) High (1) Stage (1 + 2) Stage (3 + 4) Yes
(1)
No
(0)
58.06% 42.94% 43.55% 56.45% 35.48% 64.52% 38.74% 59.68% 30.65% 69.35%

* In one patient (72 year), the primary tumor stage was not determined.